Bayesian Adaptive Design for Immunotherapy and Targeted Therapy
Seiten
2024
|
2023 ed.
Springer Verlag, Singapore
978-981-19-8467-9 (ISBN)
Springer Verlag, Singapore
978-981-19-8467-9 (ISBN)
This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.
Introduction to Adaptive Design and Delayed Outcomes.- Basics of Bayesian Statistics.- Phase I Dose-finding Design.- Phase II Design for Interim Monitoring.- Phase I-II Dose-finding Design.- Drug Combination Trial Design.- Conclusion.
| Erscheinungsdatum | 20.04.2024 |
|---|---|
| Zusatzinfo | 50 Illustrations, color; 8 Illustrations, black and white |
| Verlagsort | Singapore |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Mathematik / Informatik ► Mathematik ► Wahrscheinlichkeit / Kombinatorik |
| Medizin / Pharmazie | |
| ISBN-10 | 981-19-8467-0 / 9811984670 |
| ISBN-13 | 978-981-19-8467-9 / 9789811984679 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Stochastik: von Abweichungen bis Zufall
Buch | Softcover (2025)
De Gruyter (Verlag)
CHF 48,90
Buch | Softcover (2024)
Springer Spektrum (Verlag)
CHF 69,95
